R-Zero vs Revvity
Side-by-side comparison of AI visibility scores, market position, and capabilities
R-Zero combines UV-C disinfection hardware with IoT sensors and AI to reduce pathogen transmission and cut HVAC energy costs 20–40% in healthcare, education, and commercial buildings; raised $58M+.
About
R-Zero is an indoor health and intelligent building platform that integrates UV-C disinfection technology with IoT-connected environmental sensors and AI-driven automation. The company's product suite includes mobile and fixed UV-C disinfection units alongside occupancy and air-quality sensors that feed a building management layer capable of autonomously adjusting HVAC systems to reduce energy consumption by 20–40% without infrastructure changes. Customers include healthcare systems, K–12 schools, universities, and corporate facilities managers seeking to simultaneously reduce infection risk and operating costs.
Revvity (RVTY) reported ~$2.9B revenue in FY2024. Life science tools and diagnostics company providing instruments, reagents, and software for genomics, newborn screening, and drug discovery. HQ: Waltham, MA.
About
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.